Kromann Reumert advised Orifarm and its owners, Habico, on the deal. Orifarm secured a strategic capital investment from Carlyle Global Credit. Orifarm creates access to great...
Orifarm’s Investment Round
Coloplast’s Acquisition of Icelandic Wound Care Enterprise
Kromann Reumert advised Coloplast on the deal. Coloplast entered into an agreement to acquire Kerecis hf., an innovative, fast-growing company with a proprietary fish-skin technology platform,...
Coloplast’s $2.5 Billion Acquisition of Atos Medical
Gleiss Lutz, Kromann Reumert, Vinge, Loyens & Loeff and Fava & Associati advised Coloplast on the deal. Linklaters advised PAI Partners. Coloplast has signed an agreement...
Bavarian Nordic’s DKK 800 Million State Aid Agreement For a Danish COVID-19 Vaccine Development
Kromann Reumert has assisted Bavarian Nordic on the deal. The Danish vaccines company Bavarian Nordic A/S has entered a funding agreement with the Danish Ministry of Health...
KKR’s Acquisition of a Minority Equity Stake in Nordic Bioscience
Kromann Reumert and Sidley Austin LLP advised KKR on its purchase. Mazanti-Andersen advises the sellers. Nordic Bioscience A/S, a Danish company and world leader in biomarker...